Viridian Therapeutics, Inc. (LON:0K1R)
London
· Delayed Price · Currency is GBP · Price in USD 16.79
+0.27 (1.63%)
At close: Feb 21, 2025
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of 1.02 billion as of February 21, 2025. Its market cap has increased by 16.19% in one year.
Market Cap
1.02B
Enterprise Value
591.48M
Revenue
225.32K
Ranking
n/a
PE Ratio
n/a
Stock Price
16.79
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 138.06M to 1.02B, an increase of 638.43%. That is a compound annual growth rate of 28.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| GSK plc | 59.06B |
| Haleon | 34.94B |
| Smith & Nephew | 8.87B |
| Hikma Pharmaceuticals | 5.06B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.26B |